Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
104.33
+0.51 (0.49%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Axsome Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for Axsome Therapeutics stock have an average target of 171, with a low estimate of 105 and a high estimate of 216. The average target predicts an increase of 63.90% from the current stock price of 104.33.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $105 $171 $167 $216
Change +0.64% +63.90% +60.07% +107.04%

Analyst Ratings

The average analyst rating for Axsome Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 877667
Buy 677888
Hold 000000
Sell 000000
Strong Sell 000000
Total 141414141415

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jefferies
Jefferies
Strong Buy
Initiates
$200
Strong Buy Initiates $200 +91.70% Apr 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$200
Strong Buy Reiterates $200 +91.70% Apr 3, 2025
Needham
Needham
Strong Buy
Reiterates
$153
Strong Buy Reiterates $153 +46.65% Apr 1, 2025
Mizuho
Mizuho
Buy
Maintains
$212$216
Buy Maintains $212$216 +107.04% Mar 27, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$200
Strong Buy Reiterates $200 +91.70% Mar 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
631.96M
from 385.69M
Increased by 63.85%
Revenue Next Year
1.04B
from 631.96M
Increased by 63.93%
EPS This Year
-3.30
from -5.99
EPS Next Year
2.19
from -3.30
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
--50.04M270.60M385.69M631.96M1.04B1.55B
Revenue Growth
---440.80%42.53%63.85%63.93%49.71%
EPS
-2.77-3.47-4.60-5.27-5.99-3.302.1910.02
EPS Growth
-------356.76%
Forward PE
------47.5710.41
No. Analysts
-----191915
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 720.8M 1.3B 2.1B
Avg 632.0M 1.0B 1.6B
Low 547.8M 764.6M 1.1B

Revenue Growth

Revenue Growth 20252026202720282029
High
86.9%
110.5%
100.0%
Avg
63.9%
63.9%
49.7%
Low
42.0%
21.0%
10.6%

EPS Forecast

EPS 20252026202720282029
High -0.76 7.90 17.25
Avg -3.30 2.19 10.02
Low -4.61 -3.05 -0.77

EPS Growth

EPS Growth 20252026202720282029
High - -
686.6%
Avg - -
356.8%
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.